EXSCIENTIA LIMITED
13483814Activities of other holding companies n.e.c.
EXSCIENTIA LIMITED
Activities of other holding companies n.e.c.
Previous Company Names
Contact & Details
Contact
Registered Address
4th Floor South 3 Pancras Square King’S Cross London N1C 4AG England
Full company profile for EXSCIENTIA LIMITED (13483814), an active life sciences and medical technology company based in London, England. Incorporated 29 Jun 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2019–2023)
Cash in Bank
£259.46M
Net Assets
£355.73M
Total Liabilities
£155.00M
Turnover
£21.33M
Employees
501
Debt Ratio
30%
Financial History
Revenue, profit, EBITDA and key financial figures
2023 31 Dec Year End | 2022 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Ben Roberts Taylor | Director | American | United Kingdom | 10 Aug 2021 | Active |
See all 16 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Recursion Pharmaceuticals, Inc.
United States Of America
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Andrew Lee Hopkins
Ceased 10 Aug 2021
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 21 May 2026 | Officers | Termination of Nathan Hatfield as director on 15 May 2026 | |
| 21 May 2026 | Officers | Termination of Christopher Gibson as director on 15 May 2026 | |
| 21 May 2026 | Officers | Appointment of Andrew John Overton as director on 15 May 2026 | |
| 21 May 2026 | Officers | Appointment of Kyle Benjamin Nelson as director on 15 May 2026 | |
| 21 May 2026 | Officers | Termination of Nathan Ben Hatfield as director on 15 May 2026 |
Termination of Nathan Hatfield as director on 15 May 2026
Termination of Christopher Gibson as director on 15 May 2026
Appointment of Andrew John Overton as director on 15 May 2026
Appointment of Kyle Benjamin Nelson as director on 15 May 2026
Termination of Nathan Ben Hatfield as director on 15 May 2026
Recent Activity
Latest Activity
Termination of Nathan Hatfield as director on 15 May 2026
4 weeks ago on 21 May 2026
Termination of Christopher Gibson as director on 15 May 2026
4 weeks ago on 21 May 2026
Appointment of Andrew John Overton as director on 15 May 2026
4 weeks ago on 21 May 2026
Appointment of Kyle Benjamin Nelson as director on 15 May 2026
4 weeks ago on 21 May 2026
Termination of Nathan Ben Hatfield as director on 15 May 2026
4 weeks ago on 21 May 2026